Novel tretinoin 0.05% lotion for the once-daily treatment of moderate-to-severe acne vulgaris: assessment of safety and tolerability in subgroups.

CONCLUSIONS: A novel polymeric formulation of tretinoin 0.05% lotion provides a highly favorable safety and tolerability profile, with an incidence of erythema, dryness, and skin burning lower than that previously reported with other formulations of tretinoin.
PMID: 30935257 [PubMed - as supplied by publisher]

Source: Journal of Dermatological Treatment - April 3, 2019 Category: Dermatology Tags: J Dermatolog Treat Source Type: research